U.S. Entertainment Stock News

If you are wondering whether Tenet Healthcare at a recent close of US$183.27 still offers value or is looking stretched, the numbers behind the share price can help frame that decision. The stock has returned 1.4% over the last 7 days, while the 30 day and year to date returns of 3.7% decline and 8.1% decline sit alongside a 23.8% return over the last year and 164.3% over 3 years. Recent coverage has focused on Tenet Healthcare's position in the US hospital and healthcare services space,...

If you are wondering whether Tyson Foods at around US$63.68 is a bargain or a value trap, the key is to look past the headline share price and into what the current valuation actually reflects. The stock has slipped about 0.5% over the last week and 1.0% over the last month, but is still showing a 9.7% return year to date and 8.5% over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on Tyson Foods as a major player in U.S...

OrthoPediatrics (KIDS) opened Q1 2026 with revenue of US$59.4 million and a basic EPS loss of US$0.45, while trailing 12 month figures show revenue of US$243.3 million and a basic EPS loss of US$1.68 as the company continues to operate in the red. Over the past reported periods, revenue has moved from US$52.7 million in Q4 2024 to a range of roughly US$59 million to US$61.6 million through Q1 2026. Quarterly basic EPS has stayed loss making between about US$0.30 and US$0.69 per share. For...

Xcel Energy, NasdaqGS:XEL, has launched a follow on equity offering totaling $4.3b in new common stock. The company is raising a substantial amount of capital that is separate from routine earnings or guidance updates. Xcel Energy is coming to market with a large equity raise at a time when its shares last closed at $82.58. The stock has logged a 20.4% return over the past year and is up 10.6% year to date, alongside gains of 4.3% over the past week and 3.6% over the past month. For...

Federated Hermes (FHI) opened 2026 with Q1 results that put the focus squarely on its income statement, reporting total revenue of US$479 million and basic EPS of US$1.33, underpinned by net income of US$96 million. Over the past six reported quarters, revenue has ranged from US$425 million in Q1 2025 to US$483 million in Q4 2025, while quarterly basic EPS has moved between US$1.04 in Q4 2024 and US$1.39 in Q4 2025. This gives a clear view of how the current print fits into the recent run...

If you are wondering whether Qualys is starting to look like value at its current share price, or if the recent moves are a warning sign, this article walks you through what the numbers actually say. The stock last closed at US$88.53, with a 5.0% gain over the past week and a 2.7% move over the last month, set against a 32.4% decline year to date and a 30.8% decline over the past year. These returns sit alongside ongoing interest in cybersecurity providers and recurring revenue models, which...

In the first quarter of 2026, Butterfly Network, Inc. reported revenue of US$26.53 million versus US$21.23 million a year earlier, with its net loss narrowing to US$12.68 million from US$13.97 million, while also slightly improving basic and diluted loss per share from continuing operations to US$0.05 from US$0.06. Earlier in April 2026, the company appointed Arun Nagdev, MD as Chief Medical Officer – POCUS, adding deep clinical, ultrasound, and AI product expertise to guide its global...

If you are wondering whether Western Union is currently priced for opportunity or risk, this article will walk you through what the current share price might be implying about the stock's value. The stock last closed at US$9.21, with returns of 3.5% over the past week, 8.9% over the past month, 5.3% over the past year, and a small 0.2% decline year to date. This performance raises questions about how much of the story is already reflected in the price. Recent coverage around Western Union...

If you are wondering whether Cloudflare's current share price lines up with its underlying worth, this article walks through what the numbers actually say about value. With the stock at around US$217.50 and returns of 5.0% over 7 days, 5.9% over 30 days, 11.0% year to date, 75.1% over 1 year and 393.5% over 3 years, many investors are asking if the recent performance still leaves room for an attractive entry point or instead signals a higher level of risk. Recent headlines have focused on...

Wave Life Sciences (WVE) drew investor attention after reporting first quarter 2026 results, with sales of US$38.25 million, a net loss of US$26.09 million, and progress across several RNA based clinical programs. See our latest analysis for Wave Life Sciences. Despite the earnings beat and clinical updates, the recent 7.17% 1 month share price return to US$7.32 comes after a much steeper 43.43% 3 month share price decline. The 3 year total shareholder return of 83.46% contrasts with a 9.63%...

Dolby Laboratories (DLB) has put up a solid Q2 2026 scorecard, with revenue of US$395.6 million and basic EPS of US$1.00, setting a clear marker for how the year is shaping up. Over the past few quarters the company has seen revenue move from US$356.999 million in Q1 2025 to US$369.561 million in Q2 2025, then to US$346.706 million in Q1 2026 and now US$395.63 million, while basic EPS tracked from US$0.71 to US$0.95, then US$0.56 and now just under US$1.00. With a trailing twelve month net...

For investors considering whether H.B. Fuller is currently priced attractively or if the recent share price leaves limited potential upside, this article focuses on what the current valuation suggests. The stock last closed at US$59.95, with a 12.1% return over the past year. However, recent 7-day and 30-day returns of 4.6% and 4.0% declines, along with a small 0.6% decline year to date, indicate that sentiment has been more cautious lately. Recent coverage has centered on how H.B. Fuller is...

Builders FirstSource (BLDR) just posted Q1 2026 results with revenue of US$3.3b and a net loss of US$47.4m, translating to a basic EPS loss of US$0.43 as investors reassess how earnings power is tracking into the new year. The company has seen quarterly revenue move from US$3.7b and EPS of US$0.85 in Q1 2025 to US$3.3b and a loss per share in the latest quarter, which puts the spotlight firmly on how quickly profitability can be rebuilt from here. With trailing profit margins thinner than a...

If you are wondering whether PepsiCo's current share price offers fair value or a margin of safety, the numbers behind the stock can help frame that decision. At a last close of US$157.41, PepsiCo has recorded returns of 1.3% over 7 days, 1.8% over 30 days, 10.7% year to date, 22.4% over 1 year, negative 10.3% over 3 years and 26.3% over 5 years. This gives you several different entry points to think about. Recent coverage has focused on PepsiCo's role as a global beverages and snacks...

Wondering whether Preformed Line Products at around US$333 per share still offers value, or if the best of the opportunity is already behind it? This breakdown is designed to help you make sense of the current price. The stock has been volatile recently, with a 5.0% decline over the last 7 days, a 14.5% gain across the past month, a 57.5% return year to date, and a 143.9% return over the last 12 months. These moves have put the company back on many investors' radars, especially as they...

Wondering whether LSB Industries at US$14.77 still offers value after a strong run? This article focuses squarely on what the current price might mean for you. The stock has returned 2.6% over the last 7 days, is down 1.1% over 30 days, and shows YTD returns of 72.3% and 123.8% over 1 year that may signal changing views on its potential and risk. Recent coverage has focused on LSB Industries' share price performance and how investors are reacting to company updates. This helps explain some...

Stryker (SYK) opened 2026 with Q1 revenue of US$6.0b and basic EPS of US$1.95, while trailing twelve month figures stood at US$25.3b in revenue and basic EPS of US$8.72, giving investors a clear read on the latest run rate. The company has seen quarterly revenue move from US$5.9b in Q1 2025 to US$6.0b in Q1 2026, with basic EPS over that period shifting from US$1.71 to US$1.95, and those results sit against a backdrop of earnings growth that has outpaced revenue and supported firmer net...

Air Products and Chemicals (APD) has put down another solid quarter, with Q2 2026 revenue of US$3.2 billion and basic EPS of US$3.19, supported by net income of US$710.4 million. The company has seen quarterly revenue move from US$2,916.2 million in Q2 2025 to US$3,171.8 million in Q2 2026, while basic EPS shifted from a loss of US$7.77 per share in Q2 2025 to a profit of US$3.19. This sets up the latest release as a clean read on current profitability. With trailing net margins running at...

International Paper (IP) opened 2026 with Q1 revenue of US$6.0 billion and basic EPS of US$0.14, setting a more stable starting point after a volatile run of quarterly results. Over recent periods, the company has seen revenue move from US$3.9 billion in Q4 2024 to just over US$6.0 billion in Q4 2025. Basic EPS has swung from a profit of US$0.25 in Q4 2024 to a loss of US$4.48 in Q4 2025 and then back to a modest profit in Q1 2026, keeping investor attention firmly on the direction of margins...

If you are wondering whether KLA's current share price still offers value, you are not alone; many investors are asking the same question after such a strong run. The stock closed at US$1,726.26, with a 149.1% return over the last year, 35.4% year to date, 13.6% over the past 30 days, and a 10.8% decline over the past week, so recent moves have been far from quiet. Over the past few months, KLA has been in the spotlight as part of broader interest in semiconductor names, with attention on...

American Assets Trust (AAT) is in focus after releasing first quarter 2026 results, reporting higher sales and revenue along with significantly lower net income and earnings per share, and reaffirming its regular cash dividend. See our latest analysis for American Assets Trust. The earnings release and confirmed dividend arrived after a strong run, with a 30 day share price return of 13.24% and a 1 year total shareholder return of 16.41%. Meanwhile, the 5 year total shareholder return of a...

Emergent BioSolutions (EBS) opened 2026 with Q1 revenue of US$156.1 million and basic EPS of US$0.13, alongside trailing 12 month revenue of US$676.8 million and a TTM basic EPS loss of US$0.16. This gives investors a fresh look at how current margins compare with a still unprofitable recent track record. Over the past few quarters, the company has seen quarterly revenue move between US$140.9 million and US$231.1 million, with basic EPS swinging from a loss of US$1.04 in Q4 2025 to a profit...

Tetra Tech (TTEK) is on investors’ radar after recent share price moves, with the stock closing at US$31.67 and showing mixed short term returns over the past week, month and past 3 months. See our latest analysis for Tetra Tech. Looking beyond the latest move, the 30 day share price return of 3.06% sits against a 90 day share price decline of 15.91%. The 1 year total shareholder return of 2.96% and 5 year total shareholder return of 31.82% point to steadier long term compounding. If you are...

If you are wondering whether Elastic at US$48.61 is a bargain or just looks cheap, it helps to line up the numbers behind the share price first. The stock has seen a mixed run recently, with a 4.8% gain over the last 7 days, a 2.6% decline over 30 days, and returns of 33.0% decline year to date and 41.4% decline over 1 year that may have changed how the market prices its risk and potential. Over the past few years, investors have also had to weigh multi year returns of 14.2% decline over 3...